PMC:7228307 / 53201-53475
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
---|---|---|---|---|---|---|
1090 | 254-258 | Gene | denotes | FcγR | Gene:2213 | |
1091 | 53-57 | Gene | denotes | FcγR | Gene:2213 | |
1094 | 14-40 | Disease | denotes | PD‐1 antibody tislelizumab | MESH:D010300 | |
1095 | 169-174 | Mutation | denotes | E233P | p.E233P | |
1096 | 176-181 | Mutation | denotes | F234V | rs755807976 | |
1097 | 183-188 | Mutation | denotes | L235A | p.L235A | |
1098 | 216-221 | Mutation | denotes | D265A | p.D265A |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T409 | 19-27 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T898 | 41-44 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T899 | 53-55 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T900 | 106-110 | http://purl.obolibrary.org/obo/CLO_0007179 | denotes | L235 |
T901 | 166-167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T902 | 246-247 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T903 | 254-256 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T85014 | 14-16 | Chemical | denotes | PD | http://purl.obolibrary.org/obo/CHEBI_74756 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes | pubann:has_HGVS_notation |
---|---|---|---|---|---|---|
1090 | 254-258 | Gene | denotes | FcγR | Gene:2213 | |
1091 | 53-57 | Gene | denotes | FcγR | Gene:2213 | |
1094 | 14-40 | Disease | denotes | PD‐1 antibody tislelizumab | MESH:D010300 | |
1095 | 169-174 | Mutation | denotes | E233P | p.E233P | |
1096 | 176-181 | Mutation | denotes | F234V | rs755807976 | |
1097 | 183-188 | Mutation | denotes | L235A | p.L235A | |
1098 | 216-221 | Mutation | denotes | D265A | p.D265A |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T303 | 0-274 | Sentence | denotes | The IgG4 anti‐PD‐1 antibody tislelizumab has had its FcγR contact residues in the lower hinge E233, F234, L235 substituted with the equivalent residues of IgG2 P, V, A (E233P, F234V, L235A) as well as the additional D265A mutation which disrupts a major FcγR contact in CH2. |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T715 | 14-18 | Protein | denotes | PD‐1 | https://www.uniprot.org/uniprot/Q7M4M5|https://www.uniprot.org/uniprot/Q6NZ54|https://www.uniprot.org/uniprot/Q3KQW2|https://www.uniprot.org/uniprot/P18621|https://www.uniprot.org/uniprot/J3QL51|https://www.uniprot.org/uniprot/B5ME31|https://www.uniprot.org/uniprot/B4E3C2|https://www.uniprot.org/uniprot/B2R4H3 |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T408 | 19-27 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T303 | 0-274 | Sentence | denotes | The IgG4 anti‐PD‐1 antibody tislelizumab has had its FcγR contact residues in the lower hinge E233, F234, L235 substituted with the equivalent residues of IgG2 P, V, A (E233P, F234V, L235A) as well as the additional D265A mutation which disrupts a major FcγR contact in CH2. |